The Scientist

» drug development and ecology

Most Recent

image: Parallel Plagues

Parallel Plagues

By | April 1, 2016

Like cancer, ecological scourges result from the breakdown of regulatory processes, and may be treated with similar logic.

0 Comments

image: Another Drug Price Hike

Another Drug Price Hike

By | March 28, 2016

Valeant Pharmaceuticals is criticized for jacking up the price of a drug used in assisted suicide.

0 Comments

image: Cannabis-Based Drug for Epilepsy

Cannabis-Based Drug for Epilepsy

By | March 14, 2016

A marijuana-derived compound shows continued success in treating children with a rare form of the seizure disorder. 

0 Comments

A study suggests bats in Asia could have genes that protect them from the fungal infection that is decimating bat populations in North America.

0 Comments

image: Desperately Seeking Shut-Eye

Desperately Seeking Shut-Eye

By | March 1, 2016

New insomnia drugs are coming on the market, but drug-free therapy remains the most durable treatment.

0 Comments

image: Things That Go Bump

Things That Go Bump

By | March 1, 2016

Scientists still don’t know why animals sleep or how to define the ubiquitous behavior.

2 Comments

image: Capsule Reviews

Capsule Reviews

By | February 1, 2016

What Should a Clever Moose Eat?, The Illusion of God's Presence, GMO Sapiens, and Why We Snap

1 Comment

image: Keep Off the Grass

Keep Off the Grass

By | February 1, 2016

Ecologists focused on grasslands urge policymakers to keep forestation efforts in check.

0 Comments

image: Jason Holliday: Tree Tracker

Jason Holliday: Tree Tracker

By | February 1, 2016

Associate Professor, Virginia Tech, Department of Forest Resources and Environmental Conservation. Age: 37

0 Comments

image: Shire to Buy Baxalta for $32 Billion

Shire to Buy Baxalta for $32 Billion

By | January 12, 2016

The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech